Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Batavia Prosperindo Trans Tbk (BPTR) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Batavia Prosperindo Trans TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Batavia Prosperindo Trans Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Batavia Prosperindo Trans Tbk trades at Rp68 (market cap 240.31B, 1.62M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.4× Batavia Prosperindo Trans Tbk's market cap, and Batavia Prosperindo Trans Tbk is more actively traded (1.62M versus 817.3K). Which is the better fit depends on your goals.

BPTRLABS
Market Cap
240.31B584.6B
Volume
1.62M817.3K
Lot
16.19K8.17K
Turnover
111.23M120.01M
Average Price
68.7146.84
Value
111.23M120.01M
Indicative Equilibrium Price
68146
Indicative Equilibrium Volume
1559

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BPTR
View details
LABS
View details

About Batavia Prosperindo Trans Tbk

PT Batavia Prosperindo Trans (the “Company”) was established based on Deed No. 20 dated December 8, 2014 of Devi Yuana Lisa, S.H., as substitute Notary of Nur Muhammad Dipo Nusantara Pua Upa, S.H., M.Kn., Notary in Jakarta.

Read more on BPTR

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS